BRCA1 and triple-negative breast carcinoma: Mutations in the breast cancer susceptibility gene 1 (BRCA1) are associated with an increased risk of triple-negative breast cancer and ovarian cancer, both of which pose significant challenges in treatment due to their aggressive nature.1